XML 21 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Cash flows from operating activities:      
Net loss $ (1,929,361) $ (7,211,821) $ (10,932,590)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization 1,988,924 2,503,762 2,660,826
Share-based payment compensation 1,351,303 1,465,010 1,668,050
Non-cash professional services expenses 578,074 1,173 37,379
Gain on Estate litigation settlement 0 (5,293,319) 0
Restructuring costs 172,995 921,895 3,580,731
Payment of restructuring costs (469,248) (1,199,473) (2,274,716)
Realized gain on marketable securities 0 0 (826)
Gain on sale of cost method investment 0 0 (2,096,364)
Loss on disposal of fixed assets 45,578 0 0
Provision for returns and doubtful accounts (6,745) (64,904) (294,074)
Deferred income tax provision (126,640) 121,694 110,203
Changes in operating assets and liabilities:      
Accounts receivable 2,232,538 2,394,162 3,327,614
Prepaid expenses and other current assets (202,147) (11,072) 1,129,742
Inventory 281,959 566,897 (276,571)
Other assets 15,978 168,042 (95,052)
Accounts payable (231,598) 280,170 (1,809,000)
Accrued expenses and other long-term liabilities 674,603 (1,142,903) (11,758,230)
Deferred revenue (10,699,696) 6,991,933 5,887,953
Net cash (used in) provided by operating activities (6,323,483) 491,246 (11,134,925)
Cash flows from investing activities:      
Sales of marketable securities 15,200,100 39,131,215 33,982,164
Purchases of marketable securities (11,863,108) (41,958,829) (31,527,129)
Proceeds from sale of cost method investment 0 0 3,000,000
Transfer from restricted cash 0 750,000 0
Purchases of property and equipment (796,654) (758,906) (1,536,167)
Proceeds from sale of fixed assets 3,153 0 0
Capitalized software development costs (134,100) (184,215) (973,842)
Security deposits 229,016 (16,723) (244,814)
Purchase of intangible assets (214,500) (138,315) (128,122)
Net cash provided by (used in) investing activities 2,423,907 (3,175,773) 2,572,090
Cash flows from financing activities:      
Proceeds from exercise of stock options 59,242 24,684 697,500
Repurchase of common stock (137,858) (4,685,401) 0
Dividends paid on Series A redeemable convertible preferred stock (377,690) (777,091) 0
Proceeds from issuance of Series A redeemable convertible preferred stock, net of issuance costs 0 0 8,731,677
Net cash (used in) provided by financing activities (456,306) (5,437,808) 9,429,177
Effect of exchange rate changes on cash and cash equivalents (504,627) (292,114) (229,470)
Net (decrease) increase in cash and cash equivalents (4,860,509) (8,414,449) 636,872
Cash and cash equivalents, beginning of period 10,873,891 19,288,340 18,651,468
Cash and cash equivalents, end of period 6,013,382 10,873,891 19,288,340
Supplemental Disclosures:      
Cash paid for income taxes, net 195,895 186,194 95,593
Non-cash financing activities:      
Undistributed Series A redeemable convertible preferred stock dividends 188,805 186,904 216,379
Shares issued for Series A redeemable convertible preferred stock dividend payment $ 385,612 $ 0 $ 0